Analyst initiations: MNOV, RIG and LII
Posted May 15th 2008 11:09AM by Eric Buscemi
Filed under: Analyst Reports, Dean Foods (DF), Analyst Initiations
.gif)
MOST NOTEWORTHY: MedicNova, Transocean and Lennox were today's noteworthy initiations:
- Rodman & Renshaw is positive on MedicNova's (NASDAQ:MNOV) two primary products in development: MN-221, for the treatment of severe asthma and MN-166, an oral treatment for multiple sclerosis. The firm is also positive on MNOV's valuation; shares were initiated with an Outperform rating and $9 target.
- Transocean (NYSE:RIG) is UBS's Top Pick as they believe it is the primary beneficiary of rising deepwater dayrates. Shares were assumed with a Buy rating and $201 target.
- Suntrust initiated Lennox (NYSE:LII) with a Neutral rating and cites near-term visibility.
OTHER INITIATIONS:
Tags: analyst, dean foods, DeanFoods, df, hercules, hero, initiation, inthenews, lennox, lii, medicnova, mnov, parker-hannafin, pde, ph, pride, rig, transocean
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
